Oxidative stress plays a crucial role in neurological diseases, resulting in excessive production of reactive oxygen species, mitochondrial dysfunction and cell death. In this work, we designed and synthesized a series of tetramethylpyrazine (TMP) derivatives and investigated their abilities for scavenging free radicals and preventing against oxidative stress-induced neuronal damage in vitro. Among them, compound 22a, consisted of TMP, caffeic acid and a nitrone group, showed potent radical-scavenging activity. Compound 22a had broad neuroprotective effects, including rescuing iodoacetic acid-induced neuronal loss, preventing from tert-butylhydroperoxide (t-BHP)-induced neuronal injury. Compound 22a exerted its neuroprotective effect against t-BHP injury via activation of the phosphatidyl inositol 3-kinase (PI3K)/Akt signaling pathway. Furthermore, in a rat model of permanent middle cerebral artery occlusion, compound 22a significantly improved neurological deficits, and alleviated the infarct area and brain edema. In conclusion, our results suggest that compound 22a could be a potential neuroprotective agent for the treatment of neurological disease, particularly ischemic stroke.Key words tetramethylpyrazine; nitrone; caffeic acid; free radical; neuroprotection; permanent middle cerebral artery occlusion Ischemic stroke, resulting mainly from the interruption of cerebral blood flow, is the second cause of morbidity and mortality worldwide. Many neuroprotective drug candidates have been tested in preclinical and clinical studies, unfortunately, none have succeeded clinically. In the past few decades, great progresses have been made in understanding the pathophysiology of ischemic stroke. A cascade of biochemical events involved in ischemic stroke produces profound cellular changes, including a rapid decrease in ATP content, disruption of various ion channels, calcium overload, glutamate release, acidosis and edema.